| 0 |
VAGINAL FLATULENCE |
155 |
0.5116 |
| 1 |
HEPATIC ENZYME |
70 |
0.4698 |
| 2 |
HUMAN ANTICHIMERIC ANTIBODY POSITIVE |
139 |
0.4137 |
| 3 |
MASTITIS BACTERIAL |
26 |
0.4062 |
| 4 |
HYPOCHOLESTEROLAEMIA |
109 |
0.3088 |
| 5 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
203 |
0.3039 |
| 6 |
PSEUDOENDOPHTHALMITIS |
27 |
0.2727 |
| 7 |
SWOLLEN JOINT COUNT |
66 |
0.2640 |
| 8 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE |
27 |
0.2571 |
| 9 |
C-REACTIVE PROTEIN |
238 |
0.2567 |
| 10 |
INFECTIVE SCLERITIS |
23 |
0.2556 |
| 11 |
FACET JOINT SYNDROME |
782 |
0.2400 |
| 12 |
ORBITAL INFECTION |
21 |
0.2360 |
| 13 |
TENDER JOINT COUNT |
19 |
0.2262 |
| 14 |
LUPUS VULGARIS |
280 |
0.2222 |
| 15 |
BODY HEIGHT BELOW NORMAL |
137 |
0.2131 |
| 16 |
PSEUDOMENINGOCELE |
31 |
0.1975 |
| 17 |
NECROTISING SCLERITIS |
28 |
0.1931 |
| 18 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
383 |
0.1912 |
| 19 |
RHEUMATIC FEVER |
799 |
0.1791 |
| 20 |
SWOLLEN JOINT COUNT INCREASED |
557 |
0.1745 |
| 21 |
RETINITIS |
298 |
0.1724 |
| 22 |
BONE DENSITY INCREASED |
59 |
0.1479 |
| 23 |
NON-INFECTIOUS ENDOPHTHALMITIS |
125 |
0.1472 |
| 24 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
304 |
0.1466 |
| 25 |
SHORT STATURE |
38 |
0.1450 |
| 26 |
DISLOCATION OF VERTEBRA |
320 |
0.1402 |
| 27 |
PERIPHERAL VENOUS DISEASE |
572 |
0.1399 |
| 28 |
SERONEGATIVE ARTHRITIS |
159 |
0.1387 |
| 29 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
76 |
0.1355 |
| 30 |
ANKLE ARTHROPLASTY |
49 |
0.1350 |
| 31 |
JOINT DESTRUCTION |
205 |
0.1317 |
| 32 |
RHEGMATOGENOUS RETINAL DETACHMENT |
27 |
0.1292 |
| 33 |
DUODENAL ULCER PERFORATION |
957 |
0.1286 |
| 34 |
RHEUMATOID FACTOR POSITIVE |
727 |
0.1257 |
| 35 |
CONJUNCTIVAL ULCER |
17 |
0.1232 |
| 36 |
X-RAY ABNORMAL |
219 |
0.1223 |
| 37 |
CHORIORETINAL DISORDER |
24 |
0.1218 |
| 38 |
HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION |
43 |
0.1198 |
| 39 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
850 |
0.1185 |
| 40 |
EYE INFECTION TOXOPLASMAL |
47 |
0.1184 |
| 41 |
FOLLICULITIS |
1103 |
0.1051 |
| 42 |
GRIP STRENGTH |
24 |
0.1048 |
| 43 |
BREAST CANCER STAGE III |
676 |
0.1043 |
| 44 |
CENTRAL SEROUS CHORIORETINOPATHY |
71 |
0.1040 |
| 45 |
INJECTION SITE ATROPHY |
165 |
0.1002 |
| 46 |
MUSCLE INJURY |
810 |
0.0977 |
| 47 |
C-REACTIVE PROTEIN ABNORMAL |
627 |
0.0976 |
| 48 |
FEMALE GENITAL TRACT FISTULA |
163 |
0.0954 |
| 49 |
HELICOBACTER INFECTION |
972 |
0.0945 |
| 50 |
EYE ABSCESS |
28 |
0.0918 |
| 51 |
LIP DRY |
809 |
0.0890 |
| 52 |
HAND DEFORMITY |
1136 |
0.0865 |
| 53 |
PEMPHIGUS |
1065 |
0.0851 |
| 54 |
TOPICAL STEROID WITHDRAWAL REACTION |
31 |
0.0797 |
| 55 |
BLEPHAROSPASM |
497 |
0.0789 |
| 56 |
SYNOVITIS |
1411 |
0.0782 |
| 57 |
ANTIBODY TEST POSITIVE |
128 |
0.0771 |
| 58 |
JOINT RANGE OF MOTION DECREASED |
1008 |
0.0751 |
| 59 |
WOUND INFECTION |
809 |
0.0738 |
| 60 |
ONYCHOMADESIS |
304 |
0.0724 |
| 61 |
NECROTISING RETINITIS |
46 |
0.0719 |
| 62 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
463 |
0.0712 |
| 63 |
BONE EROSION |
242 |
0.0684 |
| 64 |
MACULAR DEGENERATION |
798 |
0.0668 |
| 65 |
PORPHYRIA ACUTE |
95 |
0.0662 |
| 66 |
HYPERCHOLESTEROLAEMIA |
629 |
0.0651 |
| 67 |
CHRONIC SINUSITIS |
242 |
0.0644 |
| 68 |
RADICULOPATHY |
165 |
0.0625 |
| 69 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
142 |
0.0616 |
| 70 |
ONYCHOMYCOSIS |
260 |
0.0592 |
| 71 |
JUVENILE IDIOPATHIC ARTHRITIS |
143 |
0.0584 |
| 72 |
BURSITIS |
708 |
0.0583 |
| 73 |
OCULAR HYPERTENSION |
113 |
0.0582 |
| 74 |
PERICARDITIS |
967 |
0.0575 |
| 75 |
LIVE BIRTH |
466 |
0.0556 |
| 76 |
PROCTITIS |
156 |
0.0556 |
| 77 |
POLYARTHRITIS |
290 |
0.0550 |
| 78 |
OBESITY |
876 |
0.0549 |
| 79 |
ADRENAL SUPPRESSION |
46 |
0.0546 |
| 80 |
GLOSSODYNIA |
1197 |
0.0534 |
| 81 |
NAIL DISORDER |
460 |
0.0525 |
| 82 |
SPINAL CORD INFARCTION |
23 |
0.0522 |
| 83 |
IRRITABLE BOWEL SYNDROME |
1087 |
0.0506 |
| 84 |
GRIP STRENGTH DECREASED |
438 |
0.0497 |
| 85 |
CHOROIDITIS |
18 |
0.0481 |
| 86 |
DRUG SPECIFIC ANTIBODY |
64 |
0.0467 |
| 87 |
WOUND |
1301 |
0.0465 |
| 88 |
FINGER DEFORMITY |
212 |
0.0437 |
| 89 |
FIBROMYALGIA |
1062 |
0.0436 |
| 90 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
451 |
0.0407 |
| 91 |
RETINAL ARTERY OCCLUSION |
95 |
0.0376 |
| 92 |
DIABETIC RETINAL OEDEMA |
19 |
0.0374 |
| 93 |
OVERLAP SYNDROME |
26 |
0.0371 |
| 94 |
ADRENAL INSUFFICIENCY |
443 |
0.0365 |
| 95 |
AUTOIMMUNE DISORDER |
353 |
0.0362 |
| 96 |
CUSHING'S SYNDROME |
25 |
0.0360 |
| 97 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1270 |
0.0357 |
| 98 |
IMPAIRED HEALING |
1147 |
0.0349 |
| 99 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
131 |
0.0348 |
| 100 |
TYPE 2 DIABETES MELLITUS |
1169 |
0.0347 |
| 101 |
SCIATICA |
551 |
0.0345 |
| 102 |
SKIN HYPOPIGMENTATION |
60 |
0.0339 |
| 103 |
HYPOPYON |
28 |
0.0338 |
| 104 |
SOFT TISSUE SWELLING |
19 |
0.0335 |
| 105 |
CHORIORETINOPATHY |
47 |
0.0330 |
| 106 |
LIVER INJURY |
808 |
0.0329 |
| 107 |
WHEELCHAIR USER |
146 |
0.0328 |
| 108 |
PRODUCT LABEL CONFUSION |
189 |
0.0324 |
| 109 |
EXOSTOSIS |
296 |
0.0324 |
| 110 |
DRUG TOLERANCE DECREASED |
90 |
0.0320 |
| 111 |
VITREOUS OPACITIES |
27 |
0.0320 |
| 112 |
OPHTHALMIC HERPES SIMPLEX |
18 |
0.0312 |
| 113 |
CYTOMEGALOVIRUS CHORIORETINITIS |
61 |
0.0312 |
| 114 |
CATARACT SUBCAPSULAR |
19 |
0.0311 |
| 115 |
SEBORRHOEIC KERATOSIS |
45 |
0.0310 |
| 116 |
LUPUS-LIKE SYNDROME |
277 |
0.0305 |
| 117 |
INFUSION SITE REACTION |
90 |
0.0301 |
| 118 |
DRUG TOLERANCE |
151 |
0.0298 |
| 119 |
ENDOPHTHALMITIS |
175 |
0.0291 |
| 120 |
PSORIATIC ARTHROPATHY |
1181 |
0.0291 |
| 121 |
RETINAL PIGMENT EPITHELIAL TEAR |
20 |
0.0288 |
| 122 |
PULMONARY FIBROSIS |
547 |
0.0285 |
| 123 |
FOOT DEFORMITY |
313 |
0.0282 |
| 124 |
JOINT DISLOCATION |
298 |
0.0282 |
| 125 |
RETINAL ISCHAEMIA |
17 |
0.0278 |
| 126 |
WALKING AID USER |
179 |
0.0271 |
| 127 |
BACK INJURY |
293 |
0.0269 |
| 128 |
TASTE DISORDER |
546 |
0.0269 |
| 129 |
GUTTATE PSORIASIS |
22 |
0.0268 |
| 130 |
PRESCRIBED UNDERDOSE |
525 |
0.0263 |
| 131 |
ATROPHY |
50 |
0.0257 |
| 132 |
SKIN WEEPING |
90 |
0.0252 |
| 133 |
LOWER LIMB FRACTURE |
484 |
0.0252 |
| 134 |
CONTRAINDICATED PRODUCT ADMINISTERED |
752 |
0.0248 |
| 135 |
STEROID WITHDRAWAL SYNDROME |
25 |
0.0245 |
| 136 |
PRESCRIBED OVERDOSE |
452 |
0.0233 |
| 137 |
C-REACTIVE PROTEIN INCREASED |
843 |
0.0231 |
| 138 |
LIPOATROPHY |
22 |
0.0231 |
| 139 |
SPONDYLITIS |
84 |
0.0231 |
| 140 |
PRODUCT USED FOR UNKNOWN INDICATION |
29 |
0.0230 |
| 141 |
PUSTULAR PSORIASIS |
79 |
0.0230 |
| 142 |
NIGHT SWEATS |
732 |
0.0227 |
| 143 |
SKIN ATROPHY |
130 |
0.0226 |
| 144 |
SOFT TISSUE DISORDER |
24 |
0.0216 |
| 145 |
INFUSION RELATED REACTION |
1423 |
0.0214 |
| 146 |
THERAPEUTIC PRODUCT CROSS-REACTIVITY |
19 |
0.0213 |
| 147 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
32 |
0.0212 |
| 148 |
GAIT INABILITY |
708 |
0.0212 |
| 149 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
17 |
0.0207 |
| 150 |
COELIAC DISEASE |
197 |
0.0201 |
| 151 |
OSTEOARTHRITIS |
848 |
0.0200 |
| 152 |
WHEEZING |
1167 |
0.0197 |
| 153 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
333 |
0.0196 |
| 154 |
NORMAL NEWBORN |
106 |
0.0195 |
| 155 |
SKIN FISSURES |
380 |
0.0194 |
| 156 |
INFLAMMATION |
983 |
0.0190 |
| 157 |
BREAST CANCER STAGE II |
157 |
0.0189 |
| 158 |
PRODUCT DELIVERY MECHANISM ISSUE |
99 |
0.0184 |
| 159 |
INFUSION SITE RASH |
25 |
0.0182 |
| 160 |
ARTHROPATHY |
1005 |
0.0181 |
| 161 |
CYSTOID MACULAR OEDEMA |
34 |
0.0180 |
| 162 |
STOMATITIS |
1094 |
0.0180 |
| 163 |
LIVER FUNCTION TEST INCREASED |
382 |
0.0178 |
| 164 |
LOWER RESPIRATORY TRACT INFECTION |
803 |
0.0176 |
| 165 |
TELANGIECTASIA |
17 |
0.0176 |
| 166 |
SCLERITIS |
28 |
0.0175 |
| 167 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
783 |
0.0175 |
| 168 |
REBOUND ATOPIC DERMATITIS |
35 |
0.0174 |
| 169 |
HIP ARTHROPLASTY |
265 |
0.0173 |
| 170 |
VAGINAL DISCHARGE |
174 |
0.0172 |
| 171 |
DERMATITIS ATOPIC |
904 |
0.0171 |
| 172 |
INFUSION SITE DISCHARGE |
30 |
0.0171 |
| 173 |
BLOOD CHOLESTEROL INCREASED |
791 |
0.0170 |
| 174 |
RASH VESICULAR |
82 |
0.0169 |
| 175 |
SPINAL FUSION SURGERY |
68 |
0.0167 |
| 176 |
BLISTER |
936 |
0.0166 |
| 177 |
ESSENTIAL HYPERTENSION |
30 |
0.0164 |
| 178 |
SKIN HAEMORRHAGE |
241 |
0.0162 |
| 179 |
XEROSIS |
20 |
0.0162 |
| 180 |
RETINAL VASCULITIS |
19 |
0.0160 |
| 181 |
MOBILITY DECREASED |
1140 |
0.0159 |
| 182 |
PARAESTHESIA ORAL |
227 |
0.0157 |
| 183 |
IMMUNODEFICIENCY |
234 |
0.0157 |
| 184 |
EPILEPSY |
468 |
0.0153 |
| 185 |
ALLERGY TO CHEMICALS |
19 |
0.0152 |
| 186 |
NASAL PRURITUS |
19 |
0.0152 |
| 187 |
ROAD TRAFFIC ACCIDENT |
630 |
0.0150 |
| 188 |
ORAL CANDIDIASIS |
198 |
0.0150 |
| 189 |
HEPATIC ENZYME INCREASED |
1023 |
0.0150 |
| 190 |
EYELID SKIN DRYNESS |
18 |
0.0148 |
| 191 |
LUNG DISORDER |
727 |
0.0148 |
| 192 |
CUSHINGOID |
47 |
0.0146 |
| 193 |
SLEEP DISORDER |
1027 |
0.0145 |
| 194 |
MUSCULOSKELETAL PAIN |
751 |
0.0143 |
| 195 |
EYELID PAIN |
29 |
0.0143 |
| 196 |
THERAPY NON-RESPONDER |
635 |
0.0141 |
| 197 |
B-LYMPHOCYTE COUNT DECREASED |
19 |
0.0140 |
| 198 |
INTRAOCULAR PRESSURE INCREASED |
178 |
0.0139 |
| 199 |
SEBORRHOEIC DERMATITIS |
23 |
0.0139 |
| 200 |
ILL-DEFINED DISORDER |
841 |
0.0138 |
| 201 |
HEPATIC CIRRHOSIS |
259 |
0.0138 |
| 202 |
SWELLING |
1285 |
0.0137 |
| 203 |
INJURY |
963 |
0.0137 |
| 204 |
JOINT STIFFNESS |
358 |
0.0136 |
| 205 |
ADVERSE REACTION |
180 |
0.0136 |
| 206 |
RETINAL DEGENERATION |
17 |
0.0131 |
| 207 |
SCRATCH |
138 |
0.0131 |
| 208 |
ECZEMA |
673 |
0.0128 |
| 209 |
EYE INJURY |
39 |
0.0128 |
| 210 |
NASAL DISCOMFORT |
101 |
0.0127 |
| 211 |
NASAL DRYNESS |
78 |
0.0124 |
| 212 |
DRUG-INDUCED LIVER INJURY |
389 |
0.0124 |
| 213 |
RHINALGIA |
34 |
0.0124 |
| 214 |
RHEUMATOID ARTHRITIS |
1391 |
0.0122 |
| 215 |
OEDEMA |
663 |
0.0122 |
| 216 |
DEATH NEONATAL |
17 |
0.0122 |
| 217 |
SKIN SWELLING |
104 |
0.0120 |
| 218 |
FREQUENT BOWEL MOVEMENTS |
321 |
0.0119 |
| 219 |
KNEE ARTHROPLASTY |
248 |
0.0118 |
| 220 |
DRY MOUTH |
952 |
0.0117 |
| 221 |
FOOT OPERATION |
58 |
0.0117 |
| 222 |
GASTROENTERITIS VIRAL |
210 |
0.0116 |
| 223 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
199 |
0.0116 |
| 224 |
DRUG INTOLERANCE |
1106 |
0.0114 |
| 225 |
CEREBROSPINAL FLUID LEAKAGE |
21 |
0.0114 |
| 226 |
LIVER DISORDER |
502 |
0.0113 |
| 227 |
REBOUND ECZEMA |
23 |
0.0112 |
| 228 |
INTENTIONAL PRODUCT USE ISSUE |
984 |
0.0112 |
| 229 |
DISCOMFORT |
685 |
0.0112 |
| 230 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
796 |
0.0112 |
| 231 |
JOINT SWELLING |
1343 |
0.0111 |
| 232 |
NODULE |
145 |
0.0111 |
| 233 |
NEURODERMATITIS |
41 |
0.0110 |
| 234 |
ULCER HAEMORRHAGE |
74 |
0.0109 |
| 235 |
POOR QUALITY PRODUCT ADMINISTERED |
113 |
0.0107 |
| 236 |
DERMATITIS CONTACT |
122 |
0.0107 |
| 237 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
28 |
0.0105 |
| 238 |
METAMORPHOPSIA |
19 |
0.0103 |
| 239 |
VITRITIS |
19 |
0.0103 |
| 240 |
DEVICE INFUSION ISSUE |
25 |
0.0101 |
| 241 |
EAR INFECTION |
264 |
0.0099 |
| 242 |
SKIN EXFOLIATION |
834 |
0.0099 |
| 243 |
JOINT EFFUSION |
68 |
0.0099 |
| 244 |
MACULAR OEDEMA |
55 |
0.0098 |
| 245 |
TREATMENT FAILURE |
813 |
0.0098 |
| 246 |
PNEUMONIA VIRAL |
31 |
0.0097 |
| 247 |
VERTIGO POSITIONAL |
17 |
0.0097 |
| 248 |
HYPOCALCAEMIA |
181 |
0.0096 |
| 249 |
EYE INFLAMMATION |
91 |
0.0095 |
| 250 |
MYOSITIS |
85 |
0.0095 |
| 251 |
OSTEOPOROSIS |
386 |
0.0094 |
| 252 |
INFUSION SITE ERYTHEMA |
79 |
0.0094 |
| 253 |
EYELID MARGIN CRUSTING |
27 |
0.0093 |
| 254 |
DELIRIUM |
324 |
0.0093 |
| 255 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
446 |
0.0093 |
| 256 |
INJECTION SITE INDENTATION |
20 |
0.0092 |
| 257 |
PUPILLARY REFLEX IMPAIRED |
17 |
0.0092 |
| 258 |
MATERNAL EXPOSURE DURING PREGNANCY |
818 |
0.0092 |
| 259 |
HYPOAESTHESIA |
1361 |
0.0091 |
| 260 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1051 |
0.0091 |
| 261 |
INFUSION SITE SWELLING |
57 |
0.0090 |
| 262 |
VITREOUS HAEMORRHAGE |
25 |
0.0090 |
| 263 |
PARANASAL SINUS DISCOMFORT |
34 |
0.0090 |
| 264 |
DISABILITY |
176 |
0.0089 |
| 265 |
INFUSION SITE PAIN |
114 |
0.0088 |
| 266 |
INFUSION SITE HAEMORRHAGE |
29 |
0.0088 |
| 267 |
THERAPEUTIC RESPONSE DECREASED |
533 |
0.0088 |
| 268 |
SINUSITIS |
900 |
0.0088 |
| 269 |
MUSCULOSKELETAL STIFFNESS |
753 |
0.0086 |
| 270 |
URTICARIA |
1436 |
0.0086 |
| 271 |
INFUSION SITE PRURITUS |
27 |
0.0085 |
| 272 |
BLOOD IRON INCREASED |
16 |
0.0085 |
| 273 |
DRY SKIN |
1135 |
0.0085 |
| 274 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
21 |
0.0085 |
| 275 |
HEPATITIS |
217 |
0.0085 |
| 276 |
PROCEDURAL PAIN |
235 |
0.0085 |
| 277 |
GASTROOESOPHAGEAL REFLUX DISEASE |
680 |
0.0084 |
| 278 |
RETINAL HAEMORRHAGE |
60 |
0.0084 |
| 279 |
EXPOSURE DURING PREGNANCY |
521 |
0.0084 |
| 280 |
DERMATITIS PSORIASIFORM |
17 |
0.0083 |
| 281 |
DYSPEPSIA |
811 |
0.0082 |
| 282 |
PAPULE |
58 |
0.0082 |
| 283 |
ROSACEA |
38 |
0.0081 |
| 284 |
GENERAL SYMPTOM |
61 |
0.0081 |
| 285 |
EAR PAIN |
157 |
0.0081 |
| 286 |
THERAPY PARTIAL RESPONDER |
125 |
0.0080 |
| 287 |
PERIPHERAL SWELLING |
1233 |
0.0080 |
| 288 |
PERIORBITAL SWELLING |
45 |
0.0080 |
| 289 |
UPPER RESPIRATORY TRACT INFECTION |
361 |
0.0078 |
| 290 |
CONGENITAL ANOMALY |
60 |
0.0077 |
| 291 |
SUSPECTED OFF LABEL USE |
35 |
0.0077 |
| 292 |
INFECTION |
1119 |
0.0077 |
| 293 |
SINUS PAIN |
18 |
0.0077 |
| 294 |
PSORIASIS |
1008 |
0.0077 |
| 295 |
TYPE I HYPERSENSITIVITY |
27 |
0.0077 |
| 296 |
CALCINOSIS |
17 |
0.0076 |
| 297 |
CHRONIC GASTRITIS |
17 |
0.0075 |
| 298 |
RETINAL DETACHMENT |
69 |
0.0075 |
| 299 |
ARTHRITIS |
588 |
0.0075 |
| 300 |
SKIN EROSION |
24 |
0.0074 |
| 301 |
PREGNANCY |
148 |
0.0074 |
| 302 |
PRURITUS |
2833 |
0.0074 |
| 303 |
MIGRAINE |
703 |
0.0074 |
| 304 |
GASTROINTESTINAL DISORDER |
659 |
0.0073 |
| 305 |
PRODUCT USE IN UNAPPROVED INDICATION |
1808 |
0.0073 |
| 306 |
POSTMENOPAUSAL HAEMORRHAGE |
19 |
0.0073 |
| 307 |
EYE PRURITUS |
243 |
0.0072 |
| 308 |
SEASONAL ALLERGY |
102 |
0.0072 |
| 309 |
WEIGHT FLUCTUATION |
75 |
0.0072 |
| 310 |
CONJUNCTIVAL HAEMORRHAGE |
27 |
0.0071 |
| 311 |
PRODUCT CONTAMINATION |
25 |
0.0070 |
| 312 |
EAR CONGESTION |
19 |
0.0070 |
| 313 |
SKIN PLAQUE |
58 |
0.0069 |
| 314 |
HYPERSENSITIVITY |
1275 |
0.0069 |
| 315 |
NECK PAIN |
382 |
0.0068 |
| 316 |
ERYTHEMA OF EYELID |
37 |
0.0068 |
| 317 |
INJECTION SITE ABSCESS |
17 |
0.0068 |
| 318 |
CONTUSION |
653 |
0.0068 |
| 319 |
SKIN HYPERTROPHY |
19 |
0.0068 |
| 320 |
ABDOMINAL DISCOMFORT |
1133 |
0.0067 |
| 321 |
RECTAL HAEMORRHAGE |
290 |
0.0067 |
| 322 |
CONJUNCTIVITIS |
125 |
0.0067 |
| 323 |
BLEPHARITIS |
27 |
0.0067 |
| 324 |
BACK DISORDER |
109 |
0.0067 |
| 325 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
37 |
0.0067 |
| 326 |
SEPTIC SHOCK |
288 |
0.0066 |
| 327 |
SKIN MASS |
44 |
0.0066 |
| 328 |
NASOPHARYNGITIS |
1213 |
0.0066 |
| 329 |
UPPER-AIRWAY COUGH SYNDROME |
54 |
0.0065 |
| 330 |
TENOSYNOVITIS |
18 |
0.0065 |
| 331 |
MACULE |
18 |
0.0065 |
| 332 |
INJECTION SITE DISCOLOURATION |
81 |
0.0065 |
| 333 |
EYE DISCHARGE |
67 |
0.0064 |
| 334 |
DERMATITIS |
134 |
0.0064 |
| 335 |
HYPERTENSION |
1350 |
0.0064 |
| 336 |
SKIN ABRASION |
30 |
0.0063 |
| 337 |
HYPERKERATOSIS |
35 |
0.0063 |
| 338 |
DERMATOMYOSITIS |
16 |
0.0063 |
| 339 |
SKIN DISCOMFORT |
17 |
0.0063 |
| 340 |
THERAPEUTIC RESPONSE SHORTENED |
209 |
0.0063 |
| 341 |
WEIGHT INCREASED |
1410 |
0.0063 |
| 342 |
MEMORY IMPAIRMENT |
864 |
0.0063 |
| 343 |
UNDERDOSE |
456 |
0.0062 |
| 344 |
HORDEOLUM |
27 |
0.0062 |
| 345 |
INCORRECT PRODUCT STORAGE |
82 |
0.0062 |
| 346 |
CONFUSIONAL STATE |
998 |
0.0062 |
| 347 |
MELANOCYTIC NAEVUS |
27 |
0.0062 |
| 348 |
PIGMENTATION DISORDER |
38 |
0.0061 |
| 349 |
TENDERNESS |
64 |
0.0061 |
| 350 |
MUSCULAR WEAKNESS |
697 |
0.0061 |
| 351 |
RASH |
2667 |
0.0061 |
| 352 |
EYELIDS PRURITUS |
19 |
0.0061 |
| 353 |
DEAFNESS NEUROSENSORY |
20 |
0.0061 |
| 354 |
THERAPEUTIC RESPONSE DELAYED |
17 |
0.0061 |
| 355 |
RHINITIS ALLERGIC |
27 |
0.0061 |
| 356 |
CONDITION AGGRAVATED |
1822 |
0.0060 |
| 357 |
MUSCLE SPASTICITY |
73 |
0.0059 |
| 358 |
MACULOPATHY |
21 |
0.0059 |
| 359 |
COLITIS ULCERATIVE |
264 |
0.0059 |
| 360 |
ALOPECIA |
1157 |
0.0059 |
| 361 |
DRY EYE |
288 |
0.0058 |
| 362 |
SEDATION |
151 |
0.0058 |
| 363 |
OCULAR HYPERAEMIA |
273 |
0.0057 |
| 364 |
NASAL CONGESTION |
337 |
0.0057 |
| 365 |
PARAESTHESIA |
900 |
0.0057 |
| 366 |
EYE PAIN |
320 |
0.0057 |
| 367 |
PRODUCT USE ISSUE |
1057 |
0.0056 |
| 368 |
BONE DENSITY DECREASED |
176 |
0.0056 |
| 369 |
ARTHRITIS INFECTIVE |
26 |
0.0056 |
| 370 |
LACRIMATION INCREASED |
169 |
0.0056 |
| 371 |
SCAB |
63 |
0.0055 |
| 372 |
VASCULAR DEVICE INFECTION |
25 |
0.0055 |
| 373 |
GLAUCOMA |
105 |
0.0054 |
| 374 |
HYPOKALAEMIA |
251 |
0.0054 |
| 375 |
AMNESIA |
352 |
0.0054 |
| 376 |
EYE INFECTION |
61 |
0.0054 |
| 377 |
VISUAL ACUITY REDUCED |
178 |
0.0054 |
| 378 |
VISUAL IMPAIRMENT |
664 |
0.0054 |
| 379 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
116 |
0.0053 |
| 380 |
PRODUCT ADMINISTRATION INTERRUPTED |
42 |
0.0053 |
| 381 |
SNEEZING |
119 |
0.0053 |
| 382 |
RASH PRURITIC |
285 |
0.0053 |
| 383 |
INJECTION SITE REACTION |
361 |
0.0052 |
| 384 |
COLITIS |
198 |
0.0052 |
| 385 |
IMPAIRED QUALITY OF LIFE |
75 |
0.0052 |
| 386 |
SKIN WARM |
30 |
0.0052 |
| 387 |
QUALITY OF LIFE DECREASED |
69 |
0.0051 |
| 388 |
VULVOVAGINAL PRURITUS |
26 |
0.0051 |
| 389 |
WOUND SECRETION |
20 |
0.0051 |
| 390 |
EPISTAXIS |
380 |
0.0051 |
| 391 |
EXPOSURE VIA BREAST MILK |
20 |
0.0050 |
| 392 |
LIMB DISCOMFORT |
155 |
0.0050 |
| 393 |
OCULAR DISCOMFORT |
56 |
0.0050 |
| 394 |
SWELLING OF EYELID |
31 |
0.0049 |
| 395 |
ASTHMA |
555 |
0.0049 |
| 396 |
MULTIPLE ALLERGIES |
38 |
0.0048 |
| 397 |
NIGHTMARE |
166 |
0.0048 |
| 398 |
RASH MACULAR |
167 |
0.0048 |
| 399 |
EAR DISCOMFORT |
49 |
0.0048 |
| 400 |
DRUG EFFECT LESS THAN EXPECTED |
70 |
0.0047 |
| 401 |
MUSCLE SPASMS |
862 |
0.0047 |
| 402 |
APPLICATION SITE DISCOLOURATION |
19 |
0.0047 |
| 403 |
ABDOMINAL PAIN UPPER |
955 |
0.0046 |
| 404 |
ARTHRITIS BACTERIAL |
19 |
0.0046 |
| 405 |
ANOSMIA |
67 |
0.0046 |
| 406 |
OEDEMA PERIPHERAL |
562 |
0.0046 |
| 407 |
SENSITIVE SKIN |
34 |
0.0046 |
| 408 |
HAEMOGLOBIN INCREASED |
21 |
0.0046 |
| 409 |
RESPIRATORY DISORDER |
137 |
0.0046 |
| 410 |
UVEITIS |
62 |
0.0046 |
| 411 |
SKIN DISCOLOURATION |
210 |
0.0046 |
| 412 |
VITAMIN D DECREASED |
39 |
0.0046 |
| 413 |
SINUS HEADACHE |
27 |
0.0045 |
| 414 |
NEPHROGENIC ANAEMIA |
21 |
0.0045 |
| 415 |
ADVERSE EVENT |
415 |
0.0045 |
| 416 |
SNORING |
17 |
0.0045 |
| 417 |
CONJUNCTIVAL HYPERAEMIA |
16 |
0.0045 |
| 418 |
MEDICATION ERROR |
249 |
0.0045 |
| 419 |
VITREOUS FLOATERS |
44 |
0.0045 |
| 420 |
INSOMNIA |
1186 |
0.0044 |
| 421 |
MUSCLE ATROPHY |
56 |
0.0044 |
| 422 |
RHINORRHOEA |
285 |
0.0044 |
| 423 |
EXPIRED PRODUCT ADMINISTERED |
145 |
0.0044 |
| 424 |
ORAL HERPES |
85 |
0.0044 |
| 425 |
STAPHYLOCOCCAL INFECTION |
143 |
0.0043 |
| 426 |
SKIN ULCER |
112 |
0.0043 |
| 427 |
NEPHROLITHIASIS |
198 |
0.0043 |
| 428 |
PAROSMIA |
32 |
0.0042 |
| 429 |
SKIN PAPILLOMA |
17 |
0.0042 |
| 430 |
FOREIGN BODY SENSATION IN EYES |
27 |
0.0042 |
| 431 |
INJECTION SITE INFLAMMATION |
21 |
0.0042 |
| 432 |
PRODUCT QUALITY ISSUE |
570 |
0.0042 |
| 433 |
SENSITIVITY TO WEATHER CHANGE |
22 |
0.0042 |
| 434 |
FLUID RETENTION |
212 |
0.0042 |
| 435 |
PRE-EXISTING CONDITION IMPROVED |
26 |
0.0042 |
| 436 |
SCAR |
71 |
0.0041 |
| 437 |
PYREXIA |
1428 |
0.0041 |
| 438 |
JOINT INJURY |
88 |
0.0041 |
| 439 |
DERMATITIS ACNEIFORM |
25 |
0.0041 |
| 440 |
SKIN DISORDER |
137 |
0.0041 |
| 441 |
VITAMIN D DEFICIENCY |
40 |
0.0041 |
| 442 |
APPLICATION SITE PAIN |
90 |
0.0041 |
| 443 |
DRUG INEFFECTIVE |
5382 |
0.0041 |
| 444 |
HIDRADENITIS |
37 |
0.0041 |
| 445 |
MUSCLE STRAIN |
35 |
0.0040 |
| 446 |
HAIR GROWTH ABNORMAL |
28 |
0.0040 |
| 447 |
DEPRESSION |
903 |
0.0040 |
| 448 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
18 |
0.0039 |
| 449 |
LIGAMENT SPRAIN |
39 |
0.0039 |
| 450 |
PAIN IN EXTREMITY |
1161 |
0.0039 |
| 451 |
DRY THROAT |
40 |
0.0039 |
| 452 |
ARTHRALGIA |
1634 |
0.0039 |
| 453 |
SINUS CONGESTION |
53 |
0.0039 |
| 454 |
INCREASED TENDENCY TO BRUISE |
36 |
0.0039 |
| 455 |
EXPOSURE VIA SKIN CONTACT |
101 |
0.0039 |
| 456 |
REBOUND EFFECT |
44 |
0.0039 |
| 457 |
ERYTHEMA |
789 |
0.0038 |
| 458 |
APPLICATION SITE SWELLING |
19 |
0.0038 |
| 459 |
BRONCHITIS |
282 |
0.0038 |
| 460 |
ASPERGILLUS INFECTION |
25 |
0.0038 |
| 461 |
VOMITING |
1782 |
0.0038 |
| 462 |
SKIN LACERATION |
41 |
0.0038 |
| 463 |
RESPIRATORY TRACT INFECTION |
98 |
0.0038 |
| 464 |
CATARACT |
224 |
0.0038 |
| 465 |
DERMATITIS ALLERGIC |
47 |
0.0037 |
| 466 |
SKIN HYPERPIGMENTATION |
32 |
0.0037 |
| 467 |
GLUCOSE TOLERANCE IMPAIRED |
22 |
0.0037 |
| 468 |
SKIN LESION |
102 |
0.0037 |
| 469 |
PAIN |
2283 |
0.0037 |
| 470 |
HAEMATOCHEZIA |
205 |
0.0037 |
| 471 |
CHAPPED LIPS |
16 |
0.0037 |
| 472 |
DECREASED APPETITE |
855 |
0.0037 |
| 473 |
PLEURAL EFFUSION |
223 |
0.0037 |
| 474 |
FURUNCLE |
29 |
0.0037 |
| 475 |
SKIN INFECTION |
41 |
0.0037 |
| 476 |
FEELING HOT |
224 |
0.0037 |
| 477 |
EYE IRRITATION |
210 |
0.0036 |
| 478 |
ECCHYMOSIS |
25 |
0.0036 |
| 479 |
SPINAL OSTEOARTHRITIS |
32 |
0.0036 |
| 480 |
HYPERVOLAEMIA |
18 |
0.0036 |
| 481 |
CHEST PAIN |
671 |
0.0036 |
| 482 |
PHARYNGITIS STREPTOCOCCAL |
39 |
0.0036 |
| 483 |
RASH ERYTHEMATOUS |
172 |
0.0036 |
| 484 |
FAECES SOFT |
26 |
0.0036 |
| 485 |
WEIGHT DECREASED |
980 |
0.0035 |
| 486 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
192 |
0.0035 |
| 487 |
SINUS DISORDER |
69 |
0.0035 |
| 488 |
DRUG EFFECT INCOMPLETE |
126 |
0.0035 |
| 489 |
VISUAL FIELD DEFECT |
25 |
0.0035 |
| 490 |
OFF LABEL USE |
3025 |
0.0035 |
| 491 |
CHOKING SENSATION |
19 |
0.0034 |
| 492 |
LIVER FUNCTION TEST ABNORMAL |
99 |
0.0034 |
| 493 |
DIZZINESS |
1678 |
0.0034 |
| 494 |
APHTHOUS ULCER |
26 |
0.0033 |
| 495 |
BREAST CANCER STAGE I |
31 |
0.0033 |
| 496 |
MALAISE |
1464 |
0.0033 |
| 497 |
EXTRA DOSE ADMINISTERED |
134 |
0.0033 |
| 498 |
INJECTION SITE VESICLES |
20 |
0.0033 |
| 499 |
PHOTOPHOBIA |
62 |
0.0033 |
| 500 |
ORAL DISORDER |
24 |
0.0033 |
| 501 |
ABDOMINAL PAIN |
757 |
0.0033 |
| 502 |
PRODUCT DOSE OMISSION IN ERROR |
92 |
0.0032 |
| 503 |
ARTHROPOD BITE |
24 |
0.0032 |
| 504 |
STREPTOCOCCAL INFECTION |
18 |
0.0032 |
| 505 |
URINE ODOUR ABNORMAL |
19 |
0.0032 |
| 506 |
INITIAL INSOMNIA |
33 |
0.0032 |
| 507 |
PRODUCT PREPARATION ISSUE |
21 |
0.0032 |
| 508 |
FLANK PAIN |
30 |
0.0032 |
| 509 |
EYE SWELLING |
119 |
0.0032 |
| 510 |
ADVERSE DRUG REACTION |
287 |
0.0032 |
| 511 |
DYSPNOEA EXERTIONAL |
120 |
0.0032 |
| 512 |
ABDOMINAL DISTENSION |
331 |
0.0032 |
| 513 |
BLINDNESS |
129 |
0.0032 |
| 514 |
HEADACHE |
1983 |
0.0032 |
| 515 |
WHITE BLOOD CELL COUNT INCREASED |
121 |
0.0032 |
| 516 |
PNEUMONIA |
1021 |
0.0032 |
| 517 |
LIQUID PRODUCT PHYSICAL ISSUE |
23 |
0.0032 |
| 518 |
NERVE COMPRESSION |
29 |
0.0031 |
| 519 |
ERYTHEMA MULTIFORME |
29 |
0.0031 |
| 520 |
THERMAL BURN |
22 |
0.0031 |
| 521 |
NECROSIS |
17 |
0.0031 |
| 522 |
INFUSION SITE EXTRAVASATION |
19 |
0.0030 |
| 523 |
CANDIDA INFECTION |
51 |
0.0030 |
| 524 |
LABORATORY TEST ABNORMAL |
89 |
0.0030 |
| 525 |
HYPERLIPIDAEMIA |
36 |
0.0030 |
| 526 |
FUNGAL INFECTION |
100 |
0.0030 |
| 527 |
OROPHARYNGEAL PAIN |
277 |
0.0030 |
| 528 |
ORAL PAIN |
67 |
0.0030 |
| 529 |
TACHYCARDIA |
265 |
0.0030 |
| 530 |
ROTATOR CUFF SYNDROME |
38 |
0.0030 |
| 531 |
INJECTION SITE SWELLING |
226 |
0.0029 |
| 532 |
INSURANCE ISSUE |
45 |
0.0029 |
| 533 |
SLEEP APNOEA SYNDROME |
56 |
0.0029 |
| 534 |
DRUG SPECIFIC ANTIBODY PRESENT |
19 |
0.0029 |
| 535 |
PRODUCT USE COMPLAINT |
46 |
0.0029 |
| 536 |
PRODUCT DISTRIBUTION ISSUE |
27 |
0.0029 |
| 537 |
ONYCHOCLASIS |
20 |
0.0029 |
| 538 |
PAIN OF SKIN |
78 |
0.0029 |
| 539 |
HEAD DISCOMFORT |
51 |
0.0029 |
| 540 |
HYPERTRANSAMINASAEMIA |
20 |
0.0029 |
| 541 |
INJECTION SITE RASH |
88 |
0.0029 |
| 542 |
GAIT DISTURBANCE |
548 |
0.0029 |
| 543 |
EYE DISORDER |
94 |
0.0029 |
| 544 |
AGEUSIA |
71 |
0.0028 |
| 545 |
FATIGUE |
2216 |
0.0028 |
| 546 |
PRODUCT PACKAGING ISSUE |
27 |
0.0028 |
| 547 |
INTENTIONAL DOSE OMISSION |
81 |
0.0028 |
| 548 |
INJECTION SITE IRRITATION |
36 |
0.0028 |
| 549 |
DIARRHOEA |
1824 |
0.0028 |
| 550 |
BRONCHIECTASIS |
19 |
0.0028 |
| 551 |
IRON DEFICIENCY ANAEMIA |
26 |
0.0028 |
| 552 |
SUNBURN |
21 |
0.0028 |
| 553 |
FACIAL PAIN |
25 |
0.0028 |
| 554 |
PSEUDOMONAS INFECTION |
24 |
0.0028 |
| 555 |
SECRETION DISCHARGE |
35 |
0.0028 |
| 556 |
THROAT IRRITATION |
125 |
0.0028 |
| 557 |
ILLNESS |
287 |
0.0028 |
| 558 |
PHOTOSENSITIVITY REACTION |
46 |
0.0028 |
| 559 |
ASTHENIA |
1045 |
0.0028 |
| 560 |
SKIN REACTION |
39 |
0.0028 |
| 561 |
PLATELET COUNT INCREASED |
36 |
0.0028 |
| 562 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
24 |
0.0028 |
| 563 |
OPTIC NEURITIS |
25 |
0.0027 |
| 564 |
TOOTH FRACTURE |
30 |
0.0027 |
| 565 |
ARTERIOSCLEROSIS CORONARY ARTERY |
18 |
0.0027 |
| 566 |
VISION BLURRED |
373 |
0.0027 |
| 567 |
CATARACT OPERATION |
16 |
0.0027 |
| 568 |
BODY TEMPERATURE INCREASED |
55 |
0.0027 |
| 569 |
NAUSEA |
2131 |
0.0027 |
| 570 |
PRODUCTIVE COUGH |
128 |
0.0027 |
| 571 |
RESPIRATORY TRACT CONGESTION |
42 |
0.0026 |
| 572 |
ANXIETY |
748 |
0.0026 |
| 573 |
LIMB INJURY |
71 |
0.0026 |
| 574 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
470 |
0.0026 |
| 575 |
INTERVERTEBRAL DISC DEGENERATION |
24 |
0.0026 |
| 576 |
PRODUCT DOSE OMISSION ISSUE |
759 |
0.0026 |
| 577 |
TOOTH INFECTION |
34 |
0.0026 |
| 578 |
DIZZINESS POSTURAL |
25 |
0.0026 |
| 579 |
PRODUCT ODOUR ABNORMAL |
27 |
0.0026 |
| 580 |
BLINDNESS TRANSIENT |
19 |
0.0026 |
| 581 |
SKIN IRRITATION |
118 |
0.0026 |
| 582 |
ABSCESS |
41 |
0.0026 |
| 583 |
BASAL CELL CARCINOMA |
40 |
0.0026 |
| 584 |
HAEMORRHOIDS |
50 |
0.0026 |
| 585 |
ASPIRATION |
28 |
0.0026 |
| 586 |
BRAIN FOG |
40 |
0.0025 |
| 587 |
PEMPHIGOID |
19 |
0.0025 |
| 588 |
GINGIVAL PAIN |
20 |
0.0025 |
| 589 |
TENDON RUPTURE |
31 |
0.0025 |
| 590 |
ECONOMIC PROBLEM |
38 |
0.0025 |
| 591 |
DYSPNOEA |
1417 |
0.0025 |
| 592 |
CARPAL TUNNEL SYNDROME |
35 |
0.0025 |
| 593 |
BOWEL MOVEMENT IRREGULARITY |
19 |
0.0025 |
| 594 |
BLOOD PRESSURE INCREASED |
378 |
0.0025 |
| 595 |
INJECTION SITE DISCOMFORT |
26 |
0.0025 |
| 596 |
LOSS OF CONSCIOUSNESS |
316 |
0.0025 |
| 597 |
PHARYNGEAL SWELLING |
24 |
0.0025 |
| 598 |
BLOOD IRON DECREASED |
29 |
0.0024 |
| 599 |
MUSCULOSKELETAL DISCOMFORT |
42 |
0.0024 |
| 600 |
TOOTHACHE |
44 |
0.0024 |
| 601 |
BURNING SENSATION |
170 |
0.0024 |
| 602 |
TEMPERATURE INTOLERANCE |
25 |
0.0024 |
| 603 |
CYST |
30 |
0.0024 |
| 604 |
APPLICATION SITE IRRITATION |
30 |
0.0024 |
| 605 |
INJECTION SITE PAIN |
739 |
0.0024 |
| 606 |
SWELLING FACE |
156 |
0.0024 |
| 607 |
DIVERTICULUM |
17 |
0.0024 |
| 608 |
GROIN PAIN |
21 |
0.0024 |
| 609 |
CONSTIPATION |
521 |
0.0024 |
| 610 |
HYPERHIDROSIS |
307 |
0.0024 |
| 611 |
FEAR OF INJECTION |
17 |
0.0024 |
| 612 |
OSTEOPENIA |
36 |
0.0024 |
| 613 |
FRUSTRATION TOLERANCE DECREASED |
19 |
0.0023 |
| 614 |
VIRAL INFECTION |
78 |
0.0023 |
| 615 |
ANAPHYLACTIC REACTION |
129 |
0.0023 |
| 616 |
CELLULITIS |
116 |
0.0023 |
| 617 |
INJECTION SITE URTICARIA |
56 |
0.0023 |
| 618 |
LOCALISED INFECTION |
55 |
0.0023 |
| 619 |
PRODUCT STORAGE ERROR |
198 |
0.0023 |
| 620 |
COUGH |
628 |
0.0022 |
| 621 |
PAIN IN JAW |
63 |
0.0022 |
| 622 |
PRODUCT CONTAINER ISSUE |
19 |
0.0022 |
| 623 |
FOOD ALLERGY |
17 |
0.0022 |
| 624 |
ULCER |
35 |
0.0022 |
| 625 |
LOW DENSITY LIPOPROTEIN INCREASED |
17 |
0.0022 |
| 626 |
ATELECTASIS |
21 |
0.0022 |
| 627 |
CLOSTRIDIUM DIFFICILE COLITIS |
23 |
0.0022 |
| 628 |
FEELING JITTERY |
41 |
0.0021 |
| 629 |
SQUAMOUS CELL CARCINOMA |
20 |
0.0021 |
| 630 |
DYSPHONIA |
124 |
0.0021 |
| 631 |
GOUT |
38 |
0.0021 |
| 632 |
SENSORY LOSS |
17 |
0.0021 |
| 633 |
RHINITIS |
17 |
0.0021 |
| 634 |
NO ADVERSE EVENT |
382 |
0.0021 |
| 635 |
INTERVERTEBRAL DISC PROTRUSION |
46 |
0.0021 |
| 636 |
OROPHARYNGEAL DISCOMFORT |
19 |
0.0021 |
| 637 |
PHARYNGITIS |
26 |
0.0021 |
| 638 |
HEPATIC STEATOSIS |
39 |
0.0021 |
| 639 |
RIB FRACTURE |
43 |
0.0021 |
| 640 |
ORAL DISCOMFORT |
29 |
0.0021 |
| 641 |
MASS |
29 |
0.0021 |
| 642 |
HICCUPS |
17 |
0.0021 |
| 643 |
ACCIDENTAL EXPOSURE TO PRODUCT |
213 |
0.0021 |
| 644 |
HOSPITALISATION |
317 |
0.0021 |
| 645 |
TOOTH ABSCESS |
21 |
0.0021 |
| 646 |
PANCREATITIS |
109 |
0.0021 |
| 647 |
NOCTURIA |
25 |
0.0021 |
| 648 |
BLINDNESS UNILATERAL |
29 |
0.0021 |
| 649 |
MENSTRUAL DISORDER |
17 |
0.0021 |
| 650 |
EMBOLISM |
17 |
0.0020 |
| 651 |
SKIN BURNING SENSATION |
146 |
0.0020 |
| 652 |
HYPOTENSION |
408 |
0.0020 |
| 653 |
THERAPEUTIC RESPONSE UNEXPECTED |
91 |
0.0020 |
| 654 |
FALL |
674 |
0.0020 |
| 655 |
HERPES ZOSTER |
116 |
0.0020 |
| 656 |
DRUG INTERACTION |
320 |
0.0020 |
| 657 |
PHARYNGEAL OEDEMA |
31 |
0.0020 |
| 658 |
DIPLOPIA |
52 |
0.0020 |
| 659 |
TENDONITIS |
31 |
0.0020 |
| 660 |
INJECTION SITE MASS |
74 |
0.0020 |
| 661 |
ANAL INCONTINENCE |
18 |
0.0020 |
| 662 |
BACTERIAL INFECTION |
37 |
0.0020 |
| 663 |
MADAROSIS |
23 |
0.0020 |
| 664 |
END STAGE RENAL DISEASE |
36 |
0.0020 |
| 665 |
IMMUNE SYSTEM DISORDER |
26 |
0.0020 |
| 666 |
EYELID PTOSIS |
20 |
0.0020 |
| 667 |
BLOOD POTASSIUM DECREASED |
59 |
0.0020 |
| 668 |
COVID-19 |
342 |
0.0019 |
| 669 |
DECREASED ACTIVITY |
21 |
0.0019 |
| 670 |
ANAEMIA |
371 |
0.0019 |
| 671 |
POST PROCEDURAL COMPLICATION |
37 |
0.0019 |
| 672 |
HOSPICE CARE |
19 |
0.0019 |
| 673 |
THROAT TIGHTNESS |
52 |
0.0019 |
| 674 |
PURPURA |
17 |
0.0019 |
| 675 |
RASH PAPULAR |
43 |
0.0019 |
| 676 |
PETECHIAE |
20 |
0.0019 |
| 677 |
INTENTIONAL PRODUCT MISUSE |
167 |
0.0019 |
| 678 |
SPINAL DISORDER |
18 |
0.0019 |
| 679 |
FOOT FRACTURE |
36 |
0.0019 |
| 680 |
GASTROINTESTINAL INFECTION |
17 |
0.0019 |
| 681 |
HEAVY MENSTRUAL BLEEDING |
17 |
0.0019 |
| 682 |
LEUKOCYTOSIS |
34 |
0.0019 |
| 683 |
URINARY TRACT INFECTION |
320 |
0.0019 |
| 684 |
PULMONARY HYPERTENSION |
39 |
0.0019 |
| 685 |
SPINAL OPERATION |
23 |
0.0019 |
| 686 |
BONE DISORDER |
34 |
0.0019 |
| 687 |
BACK PAIN |
433 |
0.0019 |
| 688 |
SLUGGISHNESS |
19 |
0.0019 |
| 689 |
BLOOD PRESSURE SYSTOLIC INCREASED |
36 |
0.0018 |
| 690 |
POOR VENOUS ACCESS |
19 |
0.0018 |
| 691 |
WRIST FRACTURE |
22 |
0.0018 |
| 692 |
KIDNEY INFECTION |
36 |
0.0018 |
| 693 |
CHRONIC KIDNEY DISEASE |
138 |
0.0018 |
| 694 |
RESTLESS LEGS SYNDROME |
33 |
0.0018 |
| 695 |
NEUROPATHY PERIPHERAL |
172 |
0.0018 |
| 696 |
APPLICATION SITE ERYTHEMA |
47 |
0.0018 |
| 697 |
PRODUCT PRESCRIBING ISSUE |
39 |
0.0018 |
| 698 |
HEART RATE INCREASED |
177 |
0.0018 |
| 699 |
OSTEONECROSIS |
58 |
0.0018 |
| 700 |
HYPOXIA |
62 |
0.0018 |
| 701 |
ANHEDONIA |
46 |
0.0017 |
| 702 |
INTERNAL HAEMORRHAGE |
20 |
0.0017 |
| 703 |
INFLUENZA |
195 |
0.0017 |
| 704 |
DISEASE RECURRENCE |
83 |
0.0017 |
| 705 |
MUSCULOSKELETAL CHEST PAIN |
27 |
0.0017 |
| 706 |
TINNITUS |
80 |
0.0017 |
| 707 |
FLUSHING |
176 |
0.0017 |
| 708 |
POLLAKIURIA |
72 |
0.0017 |
| 709 |
PULMONARY ARTERIAL HYPERTENSION |
25 |
0.0017 |
| 710 |
HYPOAESTHESIA ORAL |
26 |
0.0017 |
| 711 |
HYPOACUSIS |
74 |
0.0017 |
| 712 |
APPLICATION SITE PRURITUS |
39 |
0.0017 |
| 713 |
INJECTION SITE PRURITUS |
115 |
0.0017 |
| 714 |
FEELING ABNORMAL |
410 |
0.0017 |
| 715 |
TOOTH DISORDER |
38 |
0.0017 |
| 716 |
HIATUS HERNIA |
22 |
0.0017 |
| 717 |
PRODUCT TASTE ABNORMAL |
23 |
0.0017 |
| 718 |
INJECTION SITE INDURATION |
22 |
0.0017 |
| 719 |
LYMPHADENOPATHY |
60 |
0.0017 |
| 720 |
SURGERY |
99 |
0.0017 |
| 721 |
URINARY INCONTINENCE |
50 |
0.0017 |
| 722 |
CHROMATURIA |
38 |
0.0017 |
| 723 |
BLOOD PRESSURE FLUCTUATION |
40 |
0.0017 |
| 724 |
OXYGEN SATURATION DECREASED |
93 |
0.0017 |
| 725 |
INJECTION SITE WARMTH |
34 |
0.0017 |
| 726 |
NEURALGIA |
40 |
0.0016 |
| 727 |
MALIGNANT MELANOMA |
22 |
0.0016 |
| 728 |
HYPERSOMNIA |
47 |
0.0016 |
| 729 |
VASCULITIS |
19 |
0.0016 |
| 730 |
DYSURIA |
60 |
0.0016 |
| 731 |
THROMBOCYTOPENIA |
182 |
0.0016 |
| 732 |
GENERALISED OEDEMA |
20 |
0.0016 |
| 733 |
HAEMOPTYSIS |
45 |
0.0016 |
| 734 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
84 |
0.0016 |
| 735 |
BALANCE DISORDER |
139 |
0.0016 |
| 736 |
HOT FLUSH |
121 |
0.0016 |
| 737 |
RETCHING |
34 |
0.0016 |
| 738 |
PULMONARY CONGESTION |
21 |
0.0016 |
| 739 |
BLOOD SODIUM DECREASED |
30 |
0.0016 |
| 740 |
HEREDITARY ANGIOEDEMA |
17 |
0.0016 |
| 741 |
FLUID OVERLOAD |
23 |
0.0016 |
| 742 |
RED BLOOD CELL COUNT DECREASED |
45 |
0.0016 |
| 743 |
BONE PAIN |
92 |
0.0016 |
| 744 |
MUSCLE TWITCHING |
36 |
0.0016 |
| 745 |
UNEVALUABLE EVENT |
117 |
0.0015 |
| 746 |
RASH GENERALISED |
40 |
0.0015 |
| 747 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
55 |
0.0015 |
| 748 |
CHEST DISCOMFORT |
157 |
0.0015 |
| 749 |
SKIN CANCER |
33 |
0.0015 |
| 750 |
LIP SWELLING |
51 |
0.0015 |
| 751 |
NERVE INJURY |
17 |
0.0015 |
| 752 |
CHOLELITHIASIS |
50 |
0.0015 |
| 753 |
THIRST |
27 |
0.0015 |
| 754 |
DEVICE FAILURE |
23 |
0.0015 |
| 755 |
APHONIA |
21 |
0.0015 |
| 756 |
PALPITATIONS |
176 |
0.0015 |
| 757 |
MIDDLE INSOMNIA |
28 |
0.0015 |
| 758 |
EYE HAEMORRHAGE |
20 |
0.0015 |
| 759 |
THERAPY INTERRUPTED |
107 |
0.0015 |
| 760 |
OSTEOMYELITIS |
27 |
0.0015 |
| 761 |
FULL BLOOD COUNT DECREASED |
30 |
0.0015 |
| 762 |
FLATULENCE |
84 |
0.0015 |
| 763 |
MENORRHAGIA |
29 |
0.0015 |
| 764 |
VERTIGO |
90 |
0.0015 |
| 765 |
CYSTITIS |
47 |
0.0015 |
| 766 |
MOOD SWINGS |
47 |
0.0015 |
| 767 |
GLOMERULAR FILTRATION RATE DECREASED |
18 |
0.0015 |
| 768 |
BLOOD PRESSURE ABNORMAL |
29 |
0.0015 |
| 769 |
ACUTE RESPIRATORY FAILURE |
28 |
0.0015 |
| 770 |
HAIR COLOUR CHANGES |
18 |
0.0014 |
| 771 |
COMPLICATION ASSOCIATED WITH DEVICE |
21 |
0.0014 |
| 772 |
TREATMENT NONCOMPLIANCE |
79 |
0.0014 |
| 773 |
INJECTION SITE BRUISING |
115 |
0.0014 |
| 774 |
INJECTION SITE ERYTHEMA |
178 |
0.0014 |
| 775 |
PRURITUS GENERALISED |
31 |
0.0014 |
| 776 |
GASTRIC DISORDER |
49 |
0.0014 |
| 777 |
HEAD INJURY |
45 |
0.0014 |
| 778 |
LEUKOPENIA |
71 |
0.0014 |
| 779 |
PULMONARY MASS |
21 |
0.0014 |
| 780 |
DRUG ADMINISTRATION ERROR |
43 |
0.0014 |
| 781 |
DYSGEUSIA |
104 |
0.0014 |
| 782 |
PRESYNCOPE |
34 |
0.0014 |
| 783 |
THINKING ABNORMAL |
26 |
0.0014 |
| 784 |
IMPAIRED GASTRIC EMPTYING |
19 |
0.0014 |
| 785 |
POOR QUALITY SLEEP |
30 |
0.0014 |
| 786 |
HYPERTHYROIDISM |
20 |
0.0014 |
| 787 |
PANIC ATTACK |
50 |
0.0014 |
| 788 |
PRODUCT PRESCRIBING ERROR |
32 |
0.0013 |
| 789 |
INFLUENZA LIKE ILLNESS |
110 |
0.0013 |
| 790 |
PRODUCT ADMINISTRATION ERROR |
27 |
0.0013 |
| 791 |
DYSSTASIA |
39 |
0.0013 |
| 792 |
MYALGIA |
227 |
0.0013 |
| 793 |
GASTRITIS |
35 |
0.0013 |
| 794 |
BLOOD COUNT ABNORMAL |
20 |
0.0013 |
| 795 |
GINGIVAL BLEEDING |
18 |
0.0013 |
| 796 |
CHILLS |
153 |
0.0013 |
| 797 |
CARDIOMEGALY |
16 |
0.0013 |
| 798 |
DRUG ERUPTION |
23 |
0.0013 |
| 799 |
BEDRIDDEN |
17 |
0.0013 |
| 800 |
ANKLE FRACTURE |
20 |
0.0013 |
| 801 |
HYPOPHAGIA |
33 |
0.0013 |
| 802 |
PRODUCT PHYSICAL ISSUE |
26 |
0.0013 |
| 803 |
HAIR TEXTURE ABNORMAL |
17 |
0.0013 |
| 804 |
EATING DISORDER |
27 |
0.0013 |
| 805 |
FEELING COLD |
35 |
0.0013 |
| 806 |
HAEMOGLOBIN DECREASED |
129 |
0.0013 |
| 807 |
INCREASED APPETITE |
24 |
0.0013 |
| 808 |
HEART RATE DECREASED |
44 |
0.0013 |
| 809 |
LYMPHOCYTE COUNT DECREASED |
22 |
0.0012 |
| 810 |
HYPOKINESIA |
18 |
0.0012 |
| 811 |
RESPIRATORY DISTRESS |
34 |
0.0012 |
| 812 |
PRODUCT AVAILABILITY ISSUE |
28 |
0.0012 |
| 813 |
DIVERTICULITIS |
34 |
0.0012 |
| 814 |
DRUG EFFECT DECREASED |
66 |
0.0012 |
| 815 |
DEAFNESS |
32 |
0.0012 |
| 816 |
HYPOMAGNESAEMIA |
17 |
0.0012 |
| 817 |
PRODUCT PREPARATION ERROR |
25 |
0.0012 |
| 818 |
SEPSIS |
135 |
0.0012 |
| 819 |
GASTRIC ULCER |
23 |
0.0012 |
| 820 |
BLOOD PRESSURE DECREASED |
80 |
0.0012 |
| 821 |
PNEUMONIA ASPIRATION |
30 |
0.0012 |
| 822 |
DEEP VEIN THROMBOSIS |
78 |
0.0012 |
| 823 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
35 |
0.0012 |
| 824 |
MENSTRUATION IRREGULAR |
32 |
0.0012 |
| 825 |
CLOSTRIDIUM DIFFICILE INFECTION |
26 |
0.0012 |
| 826 |
NERVOUSNESS |
62 |
0.0012 |
| 827 |
THROMBOSIS |
95 |
0.0012 |
| 828 |
ACNE |
89 |
0.0012 |
| 829 |
WHITE BLOOD CELL COUNT DECREASED |
127 |
0.0012 |
| 830 |
ACCIDENTAL OVERDOSE |
42 |
0.0011 |
| 831 |
INCORRECT DOSE ADMINISTERED |
262 |
0.0011 |
| 832 |
IRRITABILITY |
69 |
0.0011 |
| 833 |
DEHYDRATION |
153 |
0.0011 |
| 834 |
BLOOD UREA INCREASED |
19 |
0.0011 |
| 835 |
CRYING |
41 |
0.0011 |
| 836 |
PLATELET COUNT DECREASED |
120 |
0.0011 |
| 837 |
PERICARDIAL EFFUSION |
26 |
0.0011 |
| 838 |
DISEASE PROGRESSION |
133 |
0.0011 |
| 839 |
IMPAIRED WORK ABILITY |
24 |
0.0011 |
| 840 |
SWOLLEN TONGUE |
35 |
0.0011 |
| 841 |
SYNCOPE |
112 |
0.0011 |
| 842 |
ATRIAL FIBRILLATION |
109 |
0.0011 |
| 843 |
SOMNOLENCE |
225 |
0.0011 |
| 844 |
DEPRESSED MOOD |
59 |
0.0011 |
| 845 |
HAEMATOCRIT DECREASED |
22 |
0.0011 |
| 846 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
28 |
0.0011 |
| 847 |
BLOOD POTASSIUM INCREASED |
18 |
0.0011 |
| 848 |
FAECES DISCOLOURED |
24 |
0.0011 |
| 849 |
DYSPHAGIA |
105 |
0.0011 |
| 850 |
BLOOD URINE PRESENT |
21 |
0.0011 |
| 851 |
THYROID DISORDER |
17 |
0.0011 |
| 852 |
PRODUCT DISPENSING ERROR |
24 |
0.0011 |
| 853 |
NEEDLE ISSUE |
32 |
0.0011 |
| 854 |
HYPOTHYROIDISM |
35 |
0.0011 |
| 855 |
HALLUCINATION, VISUAL |
23 |
0.0011 |
| 856 |
DIABETES MELLITUS |
83 |
0.0011 |
| 857 |
PRODUCT DOSE OMISSION |
71 |
0.0011 |
| 858 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
27 |
0.0011 |
| 859 |
FEEDING DISORDER |
22 |
0.0011 |
| 860 |
HAEMATURIA |
37 |
0.0011 |
| 861 |
RASH MACULO-PAPULAR |
24 |
0.0011 |
| 862 |
UPPER LIMB FRACTURE |
21 |
0.0011 |
| 863 |
ANAPHYLACTIC SHOCK |
27 |
0.0010 |
| 864 |
BLOOD GLUCOSE INCREASED |
197 |
0.0010 |
| 865 |
ERUCTATION |
20 |
0.0010 |
| 866 |
DELUSION |
16 |
0.0010 |
| 867 |
PANCREATITIS ACUTE |
23 |
0.0010 |
| 868 |
URINARY RETENTION |
34 |
0.0010 |
| 869 |
BLOOD TRIGLYCERIDES INCREASED |
18 |
0.0010 |
| 870 |
RENAL FAILURE |
134 |
0.0010 |
| 871 |
GALLBLADDER DISORDER |
18 |
0.0010 |
| 872 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
22 |
0.0010 |
| 873 |
ABDOMINAL PAIN LOWER |
25 |
0.0010 |
| 874 |
TREMOR |
164 |
0.0010 |
| 875 |
HERNIA |
19 |
0.0010 |
| 876 |
TRANSIENT ISCHAEMIC ATTACK |
33 |
0.0010 |
| 877 |
DEVICE USE ISSUE |
17 |
0.0010 |
| 878 |
PULMONARY EMBOLISM |
92 |
0.0010 |
| 879 |
HAEMORRHAGE |
101 |
0.0010 |
| 880 |
TOOTH LOSS |
20 |
0.0010 |
| 881 |
LETHARGY |
55 |
0.0010 |
| 882 |
INJECTION SITE HAEMORRHAGE |
76 |
0.0010 |
| 883 |
OVERDOSE |
205 |
0.0009 |
| 884 |
SPINAL FRACTURE |
19 |
0.0009 |
| 885 |
SUICIDAL IDEATION |
86 |
0.0009 |
| 886 |
HYPERGLYCAEMIA |
34 |
0.0009 |
| 887 |
AGITATION |
67 |
0.0009 |
| 888 |
STEVENS-JOHNSON SYNDROME |
20 |
0.0009 |
| 889 |
MENTAL DISORDER |
39 |
0.0009 |
| 890 |
ENCEPHALOPATHY |
22 |
0.0009 |
| 891 |
PULMONARY OEDEMA |
40 |
0.0009 |
| 892 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
30 |
0.0009 |
| 893 |
HYPONATRAEMIA |
50 |
0.0009 |
| 894 |
HEART RATE IRREGULAR |
20 |
0.0009 |
| 895 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
25 |
0.0009 |
| 896 |
MOVEMENT DISORDER |
28 |
0.0009 |
| 897 |
HIP FRACTURE |
28 |
0.0009 |
| 898 |
NEOPLASM MALIGNANT |
58 |
0.0009 |
| 899 |
CORONARY ARTERY DISEASE |
26 |
0.0009 |
| 900 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
20 |
0.0009 |
| 901 |
MOUTH ULCERATION |
18 |
0.0009 |
| 902 |
HAEMATOMA |
22 |
0.0008 |
| 903 |
FOETAL EXPOSURE DURING PREGNANCY |
69 |
0.0008 |
| 904 |
ASPARTATE AMINOTRANSFERASE INCREASED |
45 |
0.0008 |
| 905 |
PLASMA CELL MYELOMA |
33 |
0.0008 |
| 906 |
RESPIRATORY FAILURE |
61 |
0.0008 |
| 907 |
ACUTE KIDNEY INJURY |
127 |
0.0008 |
| 908 |
HALLUCINATION |
62 |
0.0008 |
| 909 |
DISTURBANCE IN ATTENTION |
44 |
0.0008 |
| 910 |
INTERNATIONAL NORMALISED RATIO INCREASED |
23 |
0.0008 |
| 911 |
SPEECH DISORDER |
42 |
0.0008 |
| 912 |
NERVOUS SYSTEM DISORDER |
25 |
0.0008 |
| 913 |
CARDIAC FAILURE CONGESTIVE |
64 |
0.0008 |
| 914 |
ABNORMAL DREAMS |
22 |
0.0008 |
| 915 |
SEIZURE |
92 |
0.0008 |
| 916 |
RENAL DISORDER |
37 |
0.0008 |
| 917 |
MENTAL STATUS CHANGES |
22 |
0.0008 |
| 918 |
ALANINE AMINOTRANSFERASE INCREASED |
48 |
0.0008 |
| 919 |
CARDIAC DISORDER |
73 |
0.0008 |
| 920 |
DRUG RESISTANCE |
20 |
0.0008 |
| 921 |
BLOOD GLUCOSE DECREASED |
37 |
0.0008 |
| 922 |
MOOD ALTERED |
21 |
0.0008 |
| 923 |
INTESTINAL OBSTRUCTION |
29 |
0.0008 |
| 924 |
ANGER |
26 |
0.0008 |
| 925 |
DEVICE DISLOCATION |
33 |
0.0008 |
| 926 |
ASCITES |
22 |
0.0007 |
| 927 |
FEAR |
20 |
0.0007 |
| 928 |
RENAL INJURY |
22 |
0.0007 |
| 929 |
WITHDRAWAL SYNDROME |
31 |
0.0007 |
| 930 |
DYSKINESIA |
30 |
0.0007 |
| 931 |
VAGINAL HAEMORRHAGE |
32 |
0.0007 |
| 932 |
PNEUMONITIS |
20 |
0.0007 |
| 933 |
ANGIOEDEMA |
32 |
0.0007 |
| 934 |
DEVICE ISSUE |
64 |
0.0007 |
| 935 |
EMOTIONAL DISORDER |
22 |
0.0007 |
| 936 |
EMOTIONAL DISTRESS |
86 |
0.0007 |
| 937 |
COGNITIVE DISORDER |
33 |
0.0007 |
| 938 |
BLOOD CREATININE INCREASED |
46 |
0.0007 |
| 939 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
141 |
0.0007 |
| 940 |
DEATH |
598 |
0.0007 |
| 941 |
DEMENTIA |
19 |
0.0007 |
| 942 |
RENAL IMPAIRMENT |
57 |
0.0007 |
| 943 |
DEVICE MALFUNCTION |
47 |
0.0007 |
| 944 |
CEREBROVASCULAR ACCIDENT |
113 |
0.0007 |
| 945 |
DYSARTHRIA |
25 |
0.0007 |
| 946 |
ERECTILE DYSFUNCTION |
17 |
0.0007 |
| 947 |
UNRESPONSIVE TO STIMULI |
17 |
0.0007 |
| 948 |
DISORIENTATION |
26 |
0.0007 |
| 949 |
RESTLESSNESS |
24 |
0.0007 |
| 950 |
CEREBRAL INFARCTION |
16 |
0.0007 |
| 951 |
NEOPLASM PROGRESSION |
22 |
0.0006 |
| 952 |
APHASIA |
19 |
0.0006 |
| 953 |
ANGINA PECTORIS |
18 |
0.0006 |
| 954 |
PSYCHOTIC DISORDER |
18 |
0.0006 |
| 955 |
BRADYCARDIA |
32 |
0.0006 |
| 956 |
FEBRILE NEUTROPENIA |
40 |
0.0006 |
| 957 |
HYPERKALAEMIA |
21 |
0.0006 |
| 958 |
ACUTE MYOCARDIAL INFARCTION |
17 |
0.0006 |
| 959 |
MULTIPLE SCLEROSIS |
27 |
0.0006 |
| 960 |
GASTROINTESTINAL HAEMORRHAGE |
47 |
0.0006 |
| 961 |
CARDIAC FAILURE |
45 |
0.0006 |
| 962 |
ARRHYTHMIA |
26 |
0.0005 |
| 963 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
39 |
0.0005 |
| 964 |
RENAL FAILURE ACUTE |
23 |
0.0005 |
| 965 |
MULTIPLE SCLEROSIS RELAPSE |
37 |
0.0005 |
| 966 |
NEUTROPHIL COUNT DECREASED |
22 |
0.0005 |
| 967 |
PANCYTOPENIA |
30 |
0.0005 |
| 968 |
INTERSTITIAL LUNG DISEASE |
25 |
0.0005 |
| 969 |
DRUG DOSE OMISSION |
81 |
0.0005 |
| 970 |
LUNG NEOPLASM MALIGNANT |
20 |
0.0005 |
| 971 |
DEVICE LEAKAGE |
21 |
0.0005 |
| 972 |
ABNORMAL BEHAVIOUR |
19 |
0.0005 |
| 973 |
MALIGNANT NEOPLASM PROGRESSION |
49 |
0.0005 |
| 974 |
NEUTROPENIA |
65 |
0.0005 |
| 975 |
HYPOGLYCAEMIA |
23 |
0.0005 |
| 976 |
CEREBRAL HAEMORRHAGE |
16 |
0.0004 |
| 977 |
AGGRESSION |
22 |
0.0004 |
| 978 |
DEVICE BREAKAGE |
17 |
0.0004 |
| 979 |
THERAPY CESSATION |
21 |
0.0004 |
| 980 |
RHABDOMYOLYSIS |
17 |
0.0004 |
| 981 |
MYOCARDIAL INFARCTION |
65 |
0.0004 |
| 982 |
DEVICE DIFFICULT TO USE |
23 |
0.0003 |
| 983 |
SUICIDE ATTEMPT |
21 |
0.0003 |
| 984 |
BREAST CANCER |
30 |
0.0003 |
| 985 |
PRODUCT SUBSTITUTION ISSUE |
18 |
0.0003 |
| 986 |
CONVULSION |
17 |
0.0003 |
| 987 |
DRUG WITHDRAWAL SYNDROME |
25 |
0.0003 |
| 988 |
DRUG DEPENDENCE |
40 |
0.0002 |
| 989 |
CARDIAC ARREST |
18 |
0.0002 |
| 990 |
PROSTATE CANCER |
17 |
0.0002 |